Hong Kong Life Sciences and Technologies Group Limited announced earnings guidance for the year ended 31 March 2019. The Group is expected to record a significant decrease in loss for the year ended 31 March 2019 as compared to the loss of approximately HKD 83 million for year ended 31 March 2018. The decrease in loss for fiscal year 2019 was mainly due to the decrease in the impairment loss on loan and interest receivables; and the absence of the impairment loss of other intangible assets in an amount of approximately HKD 12 million.